Efficacy and safety of B7-H3-targeted antibody-drug conjugates in previously treated small cell lung cancer: a systematic review and meta-analysis with a contextual comparison to topotecan

作者
Jiahui Wang,Hongqin Jiang,Junzi Niu,Lixia Liu,Yijun Wu,Jianlin Shi,Liya Liu,Shouyan Yin,Chun Feng,Lei Zhang,Mei Yang,Zihan Yi
出处
期刊:Frontiers in Immunology [Frontiers Media]
卷期号:17: 1907324-1907324
标识
DOI:10.3389/fimmu.2026.1907324
摘要

Objective: B7-H3-targeted antibody-drug conjugates (B7-H3-targeted ADCs) have shown promising antitumor effects in patients with previously treated small cell lung cancer (SCLC), yet the available evidence on their efficacy and safety has not been systematically synthesized. This study aimed to systematically evaluate the efficacy and safety of B7-H3-targeted ADCs and contextualize their clinical outcomes against standard-dose intravenous topotecan. Methods: This systematic review and meta-analysis was conducted in accordance with PRISMA guidelines. PubMed, Embase, and the Cochrane Library were searched from inception to July 7, 2026. Prospective single-arm studies of B7-H3-targeted ADCs and randomized controlled trials (RCTs) with separately extractable topotecan arms were included. Study quality was assessed using the Newcastle-Ottawa Scale and Cochrane RoB 2 tool. Random-effects models were used to pool efficacy and safety outcomes. Evidence from the two treatment groups was synthesized separately. Results for B7-H3-targeted ADCs were descriptive, whereas topotecan was used solely as an external clinical benchmark; therefore, the contextual comparison should not be interpreted as a direct comparative estimate. Results: Ten studies were included, comprising four prospective single-arm studies of B7-H3-targeted ADCs and six RCTs with eligible topotecan arms. For B7-H3-targeted ADCs, the pooled objective response rate (ORR) and disease control rate (DCR) were 54% (95% CI: 46%-62%) and 89% (95% CI: 85%-92%), respectively. The pooled median duration of response and median progression-free survival were both 5.6 months (95% CI: 4.8-6.4 and 4.7-6.5 months, respectively). The pooled incidences of any-grade and grade ≥3 treatment-related adverse events were 99% (95% CI: 98%-100%) and 61% (95% CI: 55%-67%), respectively. In the exploratory contextual analysis, ifinatamab deruxtecan achieved an ORR of 49% (95% CI: 41%-57%) and a DCR of 87% (95% CI: 81%-92%), whereas the corresponding estimates for topotecan were 18% (95% CI: 15%-22%) and 65% (95% CI: 61%-69%). Overall, the exploratory comparison showed numerically higher efficacy estimates and selected safety differences favoring ifinatamab deruxtecan compared with topotecan. Conclusions: B7-H3-targeted ADCs show promising clinical activity in patients with previously treated SCLC. In the exploratory contextual comparison, ifinatamab deruxtecan showed numerically favorable efficacy estimates and selected safety outcomes compared with topotecan. Systematic review registration: https://www.crd.york.ac.uk/PROSPERO, identifier CRD420251237597, version 3.0.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
xzcx完成签到 ,获得积分10
刚刚
方方完成签到,获得积分10
1秒前
心如止水完成签到,获得积分10
3秒前
SCINEXUS完成签到,获得积分0
3秒前
怡然绯完成签到 ,获得积分10
4秒前
书生完成签到,获得积分10
8秒前
张倾情完成签到,获得积分10
8秒前
翻斗花园吴靓靓完成签到 ,获得积分10
9秒前
Anatee完成签到,获得积分10
9秒前
忧伤的平安完成签到,获得积分10
12秒前
情怀的应助被帆320采纳,获得10
13秒前
13秒前
kevin完成签到,获得积分10
13秒前
Wei完成签到,获得积分10
17秒前
王kk完成签到 ,获得积分10
18秒前
海风完成签到,获得积分10
19秒前
辛辛那提完成签到,获得积分10
21秒前
乐无忧完成签到 ,获得积分10
21秒前
炳灿完成签到 ,获得积分10
24秒前
Skywalk满天星完成签到,获得积分10
24秒前
烂漫向梦完成签到,获得积分10
25秒前
26秒前
jie完成签到 ,获得积分10
27秒前
优雅的盼旋完成签到,获得积分10
28秒前
孤独的问柳完成签到,获得积分10
30秒前
烂漫向梦发布了新的文献求助10
30秒前
31秒前
小可爱完成签到,获得积分10
33秒前
称心忆灵完成签到,获得积分10
35秒前
leo完成签到,获得积分10
37秒前
37秒前
水本无忧87完成签到,获得积分0
37秒前
37秒前
不安丹云完成签到,获得积分10
39秒前
英姑的应助被酷酷的怀莲采纳,获得10
40秒前
忽忽完成签到,获得积分10
40秒前
小梅超顺利完成签到 ,获得积分10
40秒前
Wang完成签到 ,获得积分10
40秒前
众行绘研完成签到 ,获得积分10
41秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Hidden Empire of Finance: How Wall Street Profits from Our Cities and Fuels Global Inequality 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8166556
求助须知:如何正确求助?哪些是违规求助? 9559576
关于积分的说明 21750809
捐赠科研通 7757392
什么是DOI,文献DOI怎么找? 3429167
关于科研通互助平台的介绍 2553530
邀请新用户注册赠送积分活动 2473923